findmyKOL

Brittany Henderson, MD

Basic profile

Brigham Young University

ORCID↗NPI↗
✓ Full record
RegionMount Pleasant, SC · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Brittany Henderson is an Endocrinology/Metabolic physician affiliated with Brigham Young University. OpenAlex indexes 18 publications with 878 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
18publications

Distinct works indexed by OpenAlex, matched via ORCID.

878citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
26companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1054 Johnnie Dodds Blvd Ste A
Mount Pleasant, SC 294643153

Telephone

843-388-7545

Registry record last updated 23 Jan 2019.

View the NPPES registry record

Industry payments

26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    76.6%
    l-Thyroxine39%
    Levothyroxine Sodium36%Synthroid30%Tirosint29%Levoxyl6%
    Part D<11 patients
    l-Triiodothyronine23.8%
    Liothyronine Sodium91%Cytomel9%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    19.2%
    GLP-1 receptor agonist13.3%
    Mounjaro39%Ozempic30%Trulicity30%
    Part D<11 patients
    Biguanide (metformin)5.9%
    Metformin Hcl Er100%
    Part D≥16 patients
  • Genitourinary & hormones

    4.2%
    Progesterone4.2%
    Progesterone100%
    Part D<11 patients
Where care is delivered (Part B), 20210% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”